1. Home
  2. FOLD vs HCC Comparison

FOLD vs HCC Comparison

Compare FOLD & HCC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • FOLD
  • HCC
  • Stock Information
  • Founded
  • FOLD 2002
  • HCC 2015
  • Country
  • FOLD United States
  • HCC United States
  • Employees
  • FOLD N/A
  • HCC N/A
  • Industry
  • FOLD Biotechnology: Pharmaceutical Preparations
  • HCC Coal Mining
  • Sector
  • FOLD Health Care
  • HCC Energy
  • Exchange
  • FOLD Nasdaq
  • HCC Nasdaq
  • Market Cap
  • FOLD 2.9B
  • HCC 2.5B
  • IPO Year
  • FOLD 2007
  • HCC 2017
  • Fundamental
  • Price
  • FOLD $5.64
  • HCC $43.63
  • Analyst Decision
  • FOLD Buy
  • HCC Strong Buy
  • Analyst Count
  • FOLD 10
  • HCC 5
  • Target Price
  • FOLD $16.22
  • HCC $70.25
  • AVG Volume (30 Days)
  • FOLD 5.3M
  • HCC 889.7K
  • Earning Date
  • FOLD 08-07-2025
  • HCC 07-31-2025
  • Dividend Yield
  • FOLD N/A
  • HCC 0.74%
  • EPS Growth
  • FOLD N/A
  • HCC N/A
  • EPS
  • FOLD N/A
  • HCC 2.01
  • Revenue
  • FOLD $543,141,000.00
  • HCC $1,319,451,000.00
  • Revenue This Year
  • FOLD $19.84
  • HCC N/A
  • Revenue Next Year
  • FOLD $23.18
  • HCC $33.59
  • P/E Ratio
  • FOLD N/A
  • HCC $21.44
  • Revenue Growth
  • FOLD 28.25
  • HCC N/A
  • 52 Week Low
  • FOLD $5.62
  • HCC $38.00
  • 52 Week High
  • FOLD $12.65
  • HCC $75.53
  • Technical
  • Relative Strength Index (RSI)
  • FOLD 33.65
  • HCC 46.77
  • Support Level
  • FOLD $6.00
  • HCC $45.77
  • Resistance Level
  • FOLD $6.22
  • HCC $47.97
  • Average True Range (ATR)
  • FOLD 0.19
  • HCC 1.76
  • MACD
  • FOLD -0.01
  • HCC -0.03
  • Stochastic Oscillator
  • FOLD 2.70
  • HCC 51.33

About FOLD Amicus Therapeutics Inc.

Amicus Therapeutics Inc is a biotechnology company focused on discovering, developing and delivering medicines for people living with rare metabolic diseases. The company is engaged in developing a pipeline of medicines for rare metabolic diseases, including a rare disease gene therapy portfolio. It has a portfolio of product opportunities, including oral precision medicine for people living with Fabry disease who have amenable genetic variants; a clinical-stage, treatment paradigm for Pompe disease, and a rare disease gene therapy portfolio. The company has one segment focused on the discovery, development, and commercialization of advanced therapies to treat a range of devastating rare and orphan diseases.

About HCC Warrior Met Coal Inc.

Warrior Met Coal Inc is a U.S based company. It produces and exports of met coal that operates underground mines in Alabama. The company sells to steels manufacturers in Europe, Asia, and South America. Its mining operations consist of two underground met coal mines in Southern Appalachia's coal seam and other surface met and thermal coal mines. The Company generates ancillary revenues from the sale of natural gas extracted as a byproduct from the underground coal mines and royalty revenues from leased properties.

Share on Social Networks: